What is Agitated Solutions?
Based in Minnesota, Agitated Solutions (ASI) operates at the intersection of medical device engineering and diagnostic imaging. The company specializes in the development of advanced tools designed to refine ultrasound clarity and improve diagnostic accuracy across diverse clinical applications. A pivotal milestone for the organization occurred in early 2024, when it secured medical device licensing in Canada for its flagship innovation, the Orbis Microbubble Generator. This technology, utilized in saline contrast echocardiography, has already transitioned into active clinical use within prominent Canadian medical centers, establishing ASI as a formidable player in the ultrasound contrast agent sector.
How much funding has Agitated Solutions raised?
Agitated Solutions has raised a total of $6.5M across 1 funding round:
Stock/Share Issuance
$6.5M
Stock/Share Issuance (2025): $6.5M, investors not publicly disclosed
Key Investors in Agitated Solutions
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Agitated Solutions?
With the recent strategic investment, Agitated Solutions is well-positioned to accelerate its market penetration and expand the clinical footprint of the Orbis Microbubble Generator. The company is expected to prioritize the scaling of its manufacturing capabilities and the pursuit of additional regulatory approvals in international markets. By leveraging this capital, ASI aims to solidify its competitive advantage in the diagnostic imaging landscape, focusing on long-term value creation through enhanced patient outcomes and the continued adoption of its microbubble technology in high-acuity echocardiography settings.
See full Agitated Solutions company page
